Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice

Journal of Cellular Physiology

Volumn 228, Issue 8, 2013, Pages 1793-1798

  Mccabe, Laura R ^a,b   Irwin, Regina ^a   Schaefer, Laura ^c   Britton, Robert A ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CORTICAL BONE; ENTERITIS; FEMALE; FOLLOW UP; INTRAABDOMINAL FAT; LACTOBACILLUS REUTERI; LIVER WEIGHT; LUMBAR VERTEBRA; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TRABECULAR BONE;

ANIMALS; BONE DENSITY; FEMALE; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS REUTERI; MALE; MICE; MICE, INBRED C57BL; OSTEOPOROSIS; PROBIOTICS; SEX CHARACTERISTICS;

LACTOBACILLUS REUTERI; MUS;

EID: 84876717358     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24340     Document Type: Article

References (39)

1. Abrahamsen B, Einhorn TA. 2012. Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures. Bone 50:1196-1200.
2. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ. 2005. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 82:471-476.
3. Agrawal M, Arora S, Li J, Rahmani R, Sun L, Steinlauf AF, Mechanick JI, Zaidi M. 2011. Bone, inflammation, and inflammatory bowel disease. Curr Osteoporos Rep 9:251-257.
4. Alzamora R, O'Mahony F, Harvey BJ. 2011. Estrogen inhibits chloride secretion caused by cholera and Escherichia coli enterotoxins in female rat distal colon. Steroids 76:867-876.
5. Byrne FR, Morony S, Warmington K, Geng Z, Brown HL, Flores SA, Fiorino M, Yin SL, Hill D, Porkess V, Duryea D, Pretorius JK, Adamu S, Manoukian R, Danilenko DM, Sarosi I, Lacey DL, Kostenuik PJ, Senaldi G. 2005. CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin. Gut 54:78-86.
6. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL. 2007. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724-729.
7. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser MJ. 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621-626.
8. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, Umesaki Y, Mathis D, Benoist C, Relman DA, Kasper DL. 2012. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149:1578-1593.
9. Coe LM, Irwin R, Lippner D, McCabe LR. 2011. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. Journal of cellular physiology 226:477-483.
10. Foundation NO. 2012. National Osteoporosis Foundation.
11. Graves DT, Kayal RA. 2008. Diabetic complications and dysregulated innate immunity. Front Biosci 13:1227-1239.
12. Harris L, Senagore P, Young VB, McCabe LR. 2009. Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest Liver Physiol 296:G1020-G1029.
13. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA. 2012. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179-185.
14. Irwin, R, Lee T, Young VB, Parameswaran N. McCabe LR. in preparation. Colitis induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis.
15. Jones SE, Whitehead K, Saulnier D, Thomas CM, Versalovic J, Britton RA. 2011. Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes 2:69-79.
16. Kimble RB, Bain S, Pacifici R. 1997. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935-941.
17. Legette LL, Lee W, Martin BR, Story JA, Campbell JK, Weaver CM. 2012. Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model. J Food Sci 77:H88-H94.
18. Li JY, Tawfeek H, Bedi B, Yang X, Adams J, Gao KY, Zayzafoon M, Weitzmann MN, Pacifici R. 2011. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A 108:768-773.
19. Lin YP, Thibodeaux CH, Peña JA, Ferry GD, Versalovic J. 2008. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 14:1068-1083.
20. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220-230.
21. Manichanh C, Borruel N, Casellas F, Guarner F. 2012a. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9:599-608.
22. Manichanh C, Borruel N, Casellas F, Guarner F. 2012b. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9:599-608.
23. Mathis D, Benoist C. 2012. The influence of the microbiota on type-1 diabetes: On the threshold of a leap forward in our understanding. Immunol Rev 245:239-249.
24. Maynard CL, Elson CO, Hatton RD, Weaver CT. 2012. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489:231-241.
25. McCabe LR. 2007. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343-1357.
26. Motyl KJ, Botolin S, Irwin R, Appledorn DM, Kadakia T, Amalfitano A, Schwartz RC, McCabe LR. 2009. Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol 218:575-583.
27. Pacifici R. 2010. The immune system and bone. Arch Biochem Biophys 503:41-53.
28. Pacifici R. 2012. Role of T cells in ovariectomy induced bone loss-revisited. J Bone Miner Res 27:231-239.
29. Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, Passariello R, Cucchiara S. 2007. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13:416-423.
30. Rizzoli R, Reginster JY, Boonen S, Breart G, Diez-Perez A, Felsenberg D, Kaufman JM, Kanis JA, Cooper C. 2011. Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int 89:91-104.
31. Sjogren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Backhed F, Ohlsson C. 2012. The gut microbiota regulates bone mass in mice. J Bone Miner Res 27:1357-1367.
32. Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, Hawker G, Griffiths AM. 2007. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 13:42-50.
33. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J. 2012. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS ONE 7:e31951.
34. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. 2008. Gut, inflammation and osteoporosis: Basic and clinical concepts. Gut 57:684-694.
35. Tomita T, Kanai T, Nemoto Y, Fujii T, Nozaki K, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Totsuka T, Watanabe M. 2008. Colitogenic CD4(+) effector-memory T cells actively recirculate in chronic colitic mice. Inflamm Bowel Dis 14:1630-1640.
36. Uno JK, Kolek OI, Hines ER, Xu H, Timmermann BN, Kiela PR, Ghishan FK. 2006. The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis. Gastroenterology 131:497-509.
37. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57-63.
38. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109-1113.
39. Xue X, Lai KT, Huang JF, Gu Y, Karlsson L, Fourie A. 2006. Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib. J Pharmacol Exp Ther 317:53-60.